Mainz Biomed B.V.
MYNZ | NASDAQ
$3.59
$0.00 (0.00%)
Nov 2, 2026, 9:58 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 250.36K | 537.08K | 659.94K | 893.99K | 735.53K | 714.97K | 751.61K | 529.88K | 438.52K | 577.35K | 664.09K |
Cost of Revenue | 165.95K | 763.01K | 714.43K | 319.11K | 365.23K | 385.82K | 440.31K | 347.73K | 464.69K | 399.73K | 250.01K |
Gross Profit | 84.41K | -225.93K | -54.5K | 574.88K | 359.29K | 318.13K | 311.29K | 182.15K | -26.18K | 177.62K | 414.08K |
Operating Income | -15.3M | -13.5M | -16.98M | -18.7M | -22.04M | -25.21M | -25.25M | -26.17M | -23.37M | -9.71M | -418.9K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 231.83K | 401.95K | 339.17K | 169.05K |
Pretax Income | -17.94M | -16.21M | -18.97M | -21.65M | -16.21M | -18.31M | -25.63M | -26.39M | -25.31M | -11.67M | -534.2K |
Net Income | -18.88M | -16.21M | -18.97M | -21.65M | -16.21M | -18.45M | -25.84M | -26.45M | -25.31M | -11.67M | -534.2K |
Selling & General & Admin | 7.74M | 7.42M | 10.9M | 12.77M | 15.48M | 16.54M | 17.41M | 22.81M | 22.38M | 9.28M | 525.13K |
Research & Development | 2.43M | 4.91M | 5.36M | 5.84M | 7.1M | 9.1M | 8.21M | 3.66M | 956.83K | 466.69K | 362.07K |
Other Expenses | 5.21M | 950.41K | 656.34K | 656.34K | 1.45M | 1.51M | 283.37K | 220.63K | 10.75K | 21.5K | 26K |
Operating Expenses | 15.38M | 13.27M | 16.92M | 19.27M | 24.03M | 27.15M | 25.7M | 26.36M | 24.99M | 11.32M | 696.3K |
Interest Expense | -22.38K | 200.09K | 1.29M | 1.73M | 1.32M | 809.58K | 436.04K | 289.32K | 84.79K | 169.58K | 219.19K |
Selling & Marketing Expenses | 1.74M | 2.63M | 4.68M | 4.7M | 3.61M | 4.37M | 5.22M | 4.98M | 3.69M | 957.52K | 205.53K |
Cost & Expenses | 5.66M | 14.04M | 17.64M | 19.59M | 24.39M | 27.54M | 26.14M | 26.7M | 25.45M | 11.66M | 665.68K |
Income Tax Expense | 944.16K | n/a | n/a | n/a | n/a | 146.72K | 146.72K | n/a | n/a | n/a | 19.1K |
Shares Outstanding (Basic) | 17.85M | 6M | 3.14M | 968.23K | 558.75K | 442.04K | 29.38M | 14.16M | 13.82M | 8.81M | 12.01M |
Shares Outstanding (Diluted) | 17.85M | 6M | 3.14M | 968.23K | 558.75K | 442.04K | 29.38M | 14.16M | 14.29M | 8.81M | 12.01M |
EPS (Basic) | -1.05 | -3.08 | -10.36 | -27.44 | -31.46 | -12.63 | -1.77 | -1.87 | -2.30 | -1.32 | -0.04 |
EPS (Diluted) | -1.05 | -3.08 | -10.36 | -27.44 | -31.46 | -12.63 | -1.79 | -1.87 | -2.28 | -1.32 | -0.04 |
EBITDA | -15.03M | -12.88M | -17.83M | -19.56M | -22.08M | -25.01M | -24.28M | -25.72M | -23.28M | -9.65M | -365.82K |
EBIT | -5.41M | -13.5M | -18.86M | -20.58M | -22.88M | -26.05M | -25.18M | -26.1M | -23.37M | -9.72M | -254.63K |
Depreciation & Amortization | 267.86K | 615.72K | 1.03M | 1.02M | 795.97K | 1.03M | 979.11K | 459.43K | 90.12K | 69.93K | 47.87K |
Add to Watchlist
Select watchlists to add or remove MYNZ